Synthesis and pharmacological evaluation of 4-[2-hydroxy-3-(4-phenyl- piperazin-1-yl)-propoxy]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione

Medicinal Chemistry Research

Volumn 17, Issue 8, 2008, Pages 507-514

  Kossakowski, Jerzy ^a   Bielenica, Anna ^a   Struga, Marta ^a   Koziol, Anna E ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

5HT1A and 5HT2A receptor affinity; Cyclic imide derivative; N phenylpiperazine derivative

Indexed keywords

4 [2 HYDROXY 3 (4 PHENYLPIPERAZIN 1 YL)PROPOXY] 4 AZATRICYCLO[5.2.1.0 2,6]DEC 8 ENE 3,5 DIONE; ARIPIPRAZOLE; IMIDE; MIANSERIN; PIPERAZINE DERIVATIVE; PROPRANOLOL; QUINOLINE DERIVATIVE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ACTIVITY; DRUG SYNTHESIS; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RECEPTOR AFFINITY; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 52949126021     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-008-9094-3     Document Type: Article

References (19)

1. N Amlaiky G Leclerc A Carpy 1982 Unusual reaction of N-hydroxyphthalimido ethers leading to oxygen-nitrogen heterocycles J Org Chem 47 517 523
2. 1A and serotonin reuptake affinity Bioorg Med Chem Lett 14 4467 4470
3. Bristol-Myers Squibb Co. Instruction Sheet (2000) http://www.fda.gov
4. 50) of an enzymatic reaction Biochem Pharmacol 22 3099 3108
5. RC Dockens DE Salazar JE Fulmor M Wehling ME Arnold R Croop 2006 Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range J Clin Pharmacol 46 1308 1312
6. 1A receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation J Med Chem 48 5495 5503
7. D Gentili A Lapucci B Macchia M Macchia A Martinelli S Nencetti E Orlandini G Ferni M Pinza 1995 Synthesis and β-adrenergic activity of a series of 3-(substituted-benzylideneaminoxy)propanolamine derivatives Farmaco 50 519 526
8. PE Keck Jr SL McElroy 2003 Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic Expert Opin Investig Drugs 12 655 662
9. J Kossakowski A Wojciechowska 2006 Synthesis of oxiran-2-ylmethyl and oxiran-2-ylmethoxy derivatives of some 4-azatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5- diones as potential beta-adrenolytics Acta Pol Pharm 63 485 490
10. AE Koziol Z Chilmonczyk J Cybulski 2006 Buspirone free base Acta Cryst E62 o5616 o5618
11. CP Lawler C Prioleau MM Lewis C Mak D Jiang JA. Schetz AM Gonzalez DR Silbey RB Mailman 1999 Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes Neuropsychopharmacology 20 612 627
12. JE Leysen CJE Niemegers JH Van Neuten PM Laduron 1982 [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role Mol Pharmacol 21 301 314
13. RJ Mattson JD Catt CP Sloan Q Gao RB Carter A Gentile CD Mahle FF Matos R McGovern CP VanderMaelen FD Yocca 2003 Development of a presynaptic 5-HT1A antagonist Bioorg Med Chem Lett 13 285 288
14. JK McGavin KL Goa 2002 Aripiprazole CNS Drugs 16 779 786
15. D Middlemiss L Blakeborough SR Leather 1977 Direct evidence for an interaction of beta-adrenergic blockers with the 5-HT receptor Nature 267 289 290
16. DN Middlemiss JR Fozard 1983 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site Eur J Pharmacol 90 151 153
17. Sheldrick GM (1997) SHELXS97 and SHELXL97. University of Goettingen, Germany
18. 1A ligands Bioorg Med Chem Lett 14 1709 1712
19. L Tessler I Goldberg 2006 Crystal structures of aripiprazole, a new anti-psychotic drug, and of its inclusion compounds with methanol, ethanol and water J Incl Phenomena Macrocycl Chem 55 255 261